110 related articles for article (PubMed ID: 8676201)
21. Dosimetry of iodine-131 ethiodol in the treatment of hepatoma.
Madsen MT; Park CH; Thakur ML
J Nucl Med; 1988 Jun; 29(6):1038-44. PubMed ID: 2836572
[TBL] [Abstract][Full Text] [Related]
22. Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model.
Mairs RJ; Wideman CL; Angerson WJ; Whateley TL; Reza MS; Reeves JR; Robertson LM; Neshasteh-Riz A; Rampling R; Owens J; Allan D; Graham DI
Br J Cancer; 2000 Jan; 82(1):74-80. PubMed ID: 10638969
[TBL] [Abstract][Full Text] [Related]
23. Tumor localization and systemic absorption of intravesical instillation of radio-iodinated iododeoxyuridine in patients with bladder cancer.
Chiou RK; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Harrison KA; Taylor RJ
J Urol; 1999 Jul; 162(1):58-62. PubMed ID: 10379740
[TBL] [Abstract][Full Text] [Related]
24. 5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats.
Kassis AI; Wen PY; Van den Abbeele AD; Baranowska-Kortylewicz J; Makrigiorgos GM; Metz KR; Matalka KZ; Cook CU; Sahu SK; Black PM; Adelstein SJ
J Nucl Med; 1998 Jul; 39(7):1148-54. PubMed ID: 9669385
[TBL] [Abstract][Full Text] [Related]
25. Potential for tumor therapy with iodine-125 labeled immunoglobulins.
Adelstein SJ; Kassis AI; Baranowska-Kortylewicz J; van den Abbeele AD; Mariani G; Ito S
Int J Rad Appl Instrum B; 1991; 18(1):43-4. PubMed ID: 2010304
[TBL] [Abstract][Full Text] [Related]
26. Intrathecal 5-[125I]iodo-2'-deoxyuridine in a rat model of leptomeningeal metastases.
Sahu SK; Wen PY; Foulon CF; Nagel JS; Black PM; Adelstein SJ; Kassis AI
J Nucl Med; 1997 Mar; 38(3):386-90. PubMed ID: 9074525
[TBL] [Abstract][Full Text] [Related]
27. Targeting tumors with iodine-123 labeled deoxyuridine: distribution and DNA binding.
Thakur ML; Li J; Kim SM; Zhang JJ; Andrews D
Cancer Detect Prev; 1999; 23(1):72-7. PubMed ID: 9892993
[TBL] [Abstract][Full Text] [Related]
28. Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer.
Mariani G; Cei A; Collecchi P; Baranowska-Kortylewicz J; Van den Abbeele AD; Di Luca L; Di Stefano R; Viacava P; Ferdeghini EM; Di Sacco S
J Nucl Med; 1993 Jul; 34(7):1175-83. PubMed ID: 8315499
[TBL] [Abstract][Full Text] [Related]
29. An in vivo comparison of oral 5-iodo-2'-deoxyuridine and 5-iodo-2-pyrimidinone-2'-deoxyribose toxicity, pharmacokinetics, and DNA incorporation in athymic mouse tissues and the human colon cancer xenograft, HCT-116.
Kinsella TJ; Kunugi KA; Vielhuber KA; McCulloch W; Liu SH; Cheng YC
Cancer Res; 1994 May; 54(10):2695-700. PubMed ID: 8168099
[TBL] [Abstract][Full Text] [Related]
30. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
[TBL] [Abstract][Full Text] [Related]
31. First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR.
Rebischung C; Hoffmann D; Stefani L; Desruet MD; Wang K; Adelstein SJ; Artignan X; Vincent F; Gauchez AS; Zhang H; Fagret D; Vuillez J; Kassis AI; Balosso J
Int J Radiat Biol; 2008 Dec; 84(12):1123-9. PubMed ID: 19061137
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
[TBL] [Abstract][Full Text] [Related]
33. Effects of DNA-targeted ionizing radiation produced by 5-[125I]iodo-2'-deoxyuridine on global gene expression in primary human cells.
Sokolov MV; Neumann RD; Panyutin IG
BMC Genomics; 2007 Jun; 8():192. PubMed ID: 17594496
[TBL] [Abstract][Full Text] [Related]
34. Use of radiolabelled iododeoxyuridine as adjuvant treatment for experimental tumours of the liver.
Zager JS; Delman KA; Ebright MI; Malhotra S; Larson S; Fong Y
Br J Surg; 2003 Oct; 90(10):1225-31. PubMed ID: 14515291
[TBL] [Abstract][Full Text] [Related]
35. A phase I study of intravenous iododeoxyuridine as a clinical radiosensitizer.
Kinsella TJ; Russo A; Mitchell JB; Collins JM; Rowland J; Wright D; Glatstein E
Int J Radiat Oncol Biol Phys; 1985 Nov; 11(11):1941-6. PubMed ID: 2997090
[TBL] [Abstract][Full Text] [Related]
36. Radiotoxicity of 5-[125I]iodo-2'-deoxyuridine in mammalian cells following treatment with 5-fluoro-2'-deoxyuridine.
Kassis AI; Guptill WE; Taube RA; Adelstein SJ
J Nucl Biol Med (1991); 1991; 35(3):167-73. PubMed ID: 1840093
[TBL] [Abstract][Full Text] [Related]
37. Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine.
Tjuvajev JG; Macapinlac HA; Daghighian F; Scott AM; Ginos JZ; Finn RD; Kothari P; Desai R; Zhang J; Beattie B
J Nucl Med; 1994 Sep; 35(9):1407-17. PubMed ID: 8071684
[TBL] [Abstract][Full Text] [Related]
38. Effects of intratumoral injection of I-125 iododeoxyuridine on Ehrlich ascites carcinoma.
Hong SS; Ford EH; Alfieri AA; Bravo S
J Surg Oncol; 1989 Nov; 42(3):187-91. PubMed ID: 2811383
[TBL] [Abstract][Full Text] [Related]
39. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A
Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487
[TBL] [Abstract][Full Text] [Related]
40. In vivo therapy of neoplastic meningitis with methotrexate and 5.
Kassis AI; Dahman BA; Adelstein SJ
Acta Oncol; 2000; 39(6):731-7. PubMed ID: 11130012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
